Changzhou Qianhong Biopharma Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Changzhou Qianhong Biopharma Co., Ltd. with three other
companies in this sector in CHINA :
Guilin Sanjin Pharmaceutical Co Ltd
sales of 1.64 billion Chinese Renmimbi [US$236.45 million]
of which 90%
was Proprietary Chinese medicine),
Lionco Pharmaceutical Group Co Ltd
(1.64 billion Chinese Renmimbi [US$235.69 million]
of which 42%
was Anti-Infection), and
Yipinhong Pharmaceutical Co Ltd
(1.64 billion Chinese Renmimbi [US$236.03 million]
of which 78%
was Pharmaceutical Manufacturing).
During the year ended December of 2019, sales at
Changzhou Qianhong Biopharma Co., Ltd. were 1.67 billion Chinese Renmimbi (US$240.39 million).
increase of 26.2%
versus 2018, when the company's sales were 1.32 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Changzhou Qianhong Biopharma Co., Ltd..
Sales of Other Operations saw an increase
that was more than double the company's growth rate: sales were up
419.1% in 2019, from
323,039.95 Chinese Renmimbi to 1.68 million Chinese Renmimbi.